AMGEN INC
Display and export data
General & Ratios
Financial Statements
/
In the 'original' view, the statements are displayed just as they are being reported by the company.
In the 'standardised' view, the statements are displayed in a standardised format (line items are identical for all companies).
Add data
Click on one of the orange fields in the profile to add new information
Edit or review data
Legend (for Financial Statements)
Passed value check (?)
Failed value check (?)
Click on a coloured field in the profile to review the data
Close sidebar
Loading: 100%
AMGEN INC logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter Thousand Oaks, United States of AmericaThousand Oaks, United States of Americano data available
Employees 19,200 (as per Q1 2017)no data available
Sector Biotechnology, HealthcareBiotechnology, Healthcareno data available
Ticker AMGNno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 17120140160180200
datesClosing price (adj.)
13.10.2017183.01
11.10.2017184.15
04.10.2017188.59
27.09.2017184.87
20.09.2017188.17
13.09.2017189.70
06.09.2017178.38
30.08.2017173.65
23.08.2017169.00
16.08.2017171.39
09.08.2017172.38
02.08.2017173.29
26.07.2017174.71
19.07.2017177.98
12.07.2017172.11
05.07.2017173.09
27.06.2017169.70
20.06.2017165.17
13.06.2017163.33
06.06.2017158.50
30.05.2017152.82
23.05.2017153.04
16.05.2017158.92
09.05.2017160.97
02.05.2017161.20
25.04.2017162.43
18.04.2017159.02
11.04.2017160.86
04.04.2017162.09
28.03.2017162.44
21.03.2017164.55
14.03.2017177.63
07.03.2017174.93
28.02.2017174.09
21.02.2017170.75
14.02.2017165.73
07.02.2017163.40
31.01.2017153.46
24.01.2017148.73
17.01.2017151.62
10.01.2017155.50
03.01.2017147.64
27.12.2016145.31
19.12.2016144.71
12.12.2016142.77
05.12.2016142.31
28.11.2016142.09
21.11.2016142.56
14.11.2016143.41
07.11.2016135.43
31.10.2016137.32
24.10.2016154.45
17.10.2016158.20
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
 183.01n/a
Market Capitalisation
in million USD
 134,585n/a
Enterprise Value
in million USD
 131,928n/a
Common Shares Outstanding
as per Apr 18, 2017
 735,399,128n/a
Preferred Shares Outstanding
as per Apr 18, 2017
 n/a
Average Basic Shares Outstanding
TTM
 744,000,000n/a
Average Diluted Shares Outstanding
TTM
 749,250,000n/a
Index Membership
n/a
Business Summary
Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.
no data available
Key Financials & Ratios (all figures TTM as per Sep 30, 2016, million USD, full statements further below)
Profit & Loss
Revenues 22,562n/a
Gross Profit 18,396n/a
Operating Income 9,342n/a
EBITDA 11,430n/a
Net Profit 7,587n/a
Balance Sheet
Cash and Cash Equivalents 37,980n/a
Receivables 3,186n/a
Total Current Assets 45,844n/a
PP&E 4,912n/a
Total Assets 78,150n/a
Accounts Payable 825n/a
Current Debt 4,797n/a
Total Current Liabilities 10,542n/a
Long-Term Debt 30,526n/a
Total Liabilities 47,377n/a
Total Equity 30,773n/a
Cash Flow
Depreciation & Amortisation 2,088n/a
Change in Working Capital -696n/a
Operating Cash Flow 8,673n/a
Net Change in PP&E and Intangibles -753n/a
Investing Cash Flow -7,669n/a
Dividends Paid -2,847n/a
Financing Cash Flow -745n/a
Total Change in Cash 259n/a
Free Cash Flow 8,775n/a
Profitability Ratios
Gross Margin 81.5%n/a
Operating Margin 41.4%n/a
Net Profit Margin 33.6%n/a
Return on Equity 24.7%n/a
Return on Assets 9.7%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA 11.54n/a
EV/Sales 5.85n/a
Book to Market Value 0.23n/a
Other Ratios
Current Ratio 434.9%n/a
Liabilities to Equity Ratio 154.0%n/a
Debt to Assets Ratio 45.2%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Revenue
14,771
15,003
14,642
15,053
15,582
17,265
18,676
20,063
21,662
Sales & Services Revenue
0
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
0
Cost of revenue
-2,548
-2,296
-2,091
-2,220
-2,708
-3,199
-3,346
-4,422
-4,227
Cost of Goods & Services
0
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
0
Gross Profit
12,223
12,707
12,551
12,833
12,874
14,066
15,330
15,641
17,435
Other Operating Income
0
0
0
0
0
0
0
0
0
Operating Expenses
-7,653
-7,493
-7,045
-7,288
-8,562
-8,489
-9,463
-9,450
-8,965
Selling, General & Administrative
-4,089
-4,169
-3,887
-4,100
-5,395
-5,109
-5,380
-5,153
-4,895
Selling & Marketing
0
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
0
Research & Development
-3,266
-3,030
-2,864
-2,894
-3,167
-3,380
-4,083
-4,297
-4,070
Depreciation & Amortization
-298
-294
-294
-294
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
0
Operating Income (Loss)
4,570
5,214
5,506
5,545
4,312
5,577
5,867
6,191
8,470
Non-Operating Income (Loss)
-187
-199
-302
-228
-162
-568
-602
-606
-492
Interest Expense, net
-496
-551
-578
-604
-610
-1,053
-1,022
-1,071
-1,095
Interest Expense
0
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
309
352
276
376
448
485
420
465
603
Pretax Income (Loss), Adjusted
4,383
5,015
5,204
5,317
4,150
5,009
5,265
5,585
7,978
Abnormal Gains (Losses)
-590
0
0
0
0
0
0
0
0
Acquired In-Process R&D
0
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
0
Pretax Income (Loss)
3,793
5,015
5,204
5,317
4,150
5,009
5,265
5,585
7,978
Income Tax (Expense) Benefit, net
-715
-963
-599
-690
-467
-664
-184
-427
-1,039
Current Income Tax
0
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
3,078
4,052
4,605
4,627
3,683
4,345
5,081
5,158
6,939
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
3,078
4,052
4,605
4,627
3,683
4,345
5,081
5,158
6,939
Minority Interest
0
0
0
0
0
0
0
0
0
Net Income
3,078
4,052
4,605
4,627
3,683
4,345
5,081
5,158
6,939
Preferred Dividends
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
3,078
4,052
4,605
4,627
3,683
4,345
5,081
5,158
6,939
Remarks
restated on Mar 1, 2010 n/a
calculated values,
restated on Feb 25, 2011 n/a
calculated values,
restated on Feb 29, 2012 n/a
calculated values,
restated on Feb 27, 2013 n/a
calculated values,
restated on Feb 24, 2014 n/a
calculated values,
restated on Feb 19, 2015 n/a
calculated values,
restated on Feb 16, 2016 n/a
calculated values,
restated on Feb 14, 2017 n/a
calculated values,
restated on Feb 14, 2017 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
9,552
13,442
17,422
20,641
24,061
19,401
27,026
31,382
Cash & Cash Equivalents
n/a
1,774
2,884
3,287
6,946
3,257
3,805
3,731
4,144
Short Term Investments
n/a
7,778
10,558
14,135
13,695
20,804
15,596
23,295
27,238
Accounts & Notes Receivable
n/a
2,073
2,109
2,335
2,896
2,518
2,697
2,546
2,995
Accounts Receivable, Net
n/a
2,073
2,109
2,335
2,896
2,518
2,697
2,546
2,995
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
0
Inventories
n/a
2,075
2,220
2,022
2,484
2,744
3,019
2,647
2,435
Raw Materials
n/a
0
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
0
Other Short Term Assets
n/a
1,521
1,161
1,350
1,572
1,886
2,250
2,494
1,703
Prepaid Expenses
n/a
0
0
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
1,521
1,161
1,350
1,572
1,886
2,250
2,494
1,703
Total Current Assets
n/a
15,221
18,932
23,129
27,593
31,209
27,367
34,713
38,515
Property, Plant & Equipment, Net
n/a
5,879
5,738
5,522
5,420
5,326
5,349
5,223
4,907
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
0
Other Long Term Assets
n/a
15,327
14,959
14,835
15,858
17,763
33,409
29,073
28,027
Intangible Assets
n/a
2,988
2,567
2,230
2,584
3,968
13,262
12,693
11,641
Goodwill
n/a
11,339
11,335
11,334
11,750
12,662
14,968
14,788
14,787
Other Intangible Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
1,000
1,057
1,271
1,524
1,133
5,179
1,592
1,599
Total Noncurrent Assets
n/a
21,206
20,697
20,357
21,278
23,089
38,758
34,296
32,934
Total Assets
n/a
36,427
39,629
43,486
48,871
54,298
66,125
69,009
71,449
Liabilities and owners' equity
Payables & Accruals
n/a
3,886 3886000000
3,873 3873000000
4,082 4082000000
5,670 5670000000
5,696 5696000000
5,442 5442000000
6,508 6508000000
6,417 6417000000
Accounts Payable
n/a
504 504000000
574 574000000
716 716000000
642 642000000
905 905000000
787 787000000
995 995000000
965 965000000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
3,382 3382000000
3,299 3299000000
3,366 3366000000
5,028 5028000000
4,791 4791000000
4,655 4655000000
5,513 5513000000
5,452 5452000000
Short Term Debt
n/a
1,000 1000000000
0 0
2,488 2488000000
84 84000000
2,495 2495000000
2,505 2505000000
500 500000000
2,247 2247000000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Current Liabilities
n/a
4,886 4886000000
3,873 3873000000
6,570 6570000000
5,754 5754000000
8,191 8191000000
7,947 7947000000
7,008 7008000000
8,664 8664000000
Long Term Debt
n/a
8,352 8352000000
10,601 10601000000
10,874 10874000000
21,344 21344000000
24,034 24034000000
29,623 29623000000
30,215 30215000000
29,182 29182000000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
2,304 2304000000
2,488 2488000000
2,098 2098000000
2,744 2744000000
3,013 3013000000
6,459 6459000000
6,008 6008000000
5,520 5520000000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
3,498 3498000000
3,461 3461000000
2,239 2239000000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
2,304 2304000000
2,488 2488000000
2,098 2098000000
2,744 2744000000
3,013 3013000000
2,961 2961000000
2,547 2547000000
3,281 3281000000
Total Noncurrent Liabilities
n/a
10,656 10656000000
13,089 13089000000
12,972 12972000000
24,088 24088000000
27,047 27047000000
36,082 36082000000
36,223 36223000000
34,702 34702000000
Total Liabilities
n/a
15,542 15542000000
16,962 16962000000
19,542 19542000000
29,842 29842000000
35,238 35238000000
44,029 44029000000
43,231 43231000000
43,366 43366000000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
26,441 26441000000
26,944 26944000000
27,299 27299000000
27,777 27777000000
29,337 29337000000
29,891 29891000000
30,410 30410000000
30,649 30649000000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
n/a
-5,673 -5673000000
-4,322 -4322000000
-3,508 -3508000000
-8,919 -8919000000
-10,423 -10423000000
-7,634 -7634000000
-4,624 -4624000000
-2,086 -2086000000
Other Equity
n/a
117 117000000
45 45000000
153 153000000
171 171000000
146 146000000
-161 -161000000
-8 -8000000
-480 -480000000
Equity Before Minority Interest
n/a
20,885 20885000000
22,667 22667000000
23,944 23944000000
19,029 19029000000
19,060 19060000000
22,096 22096000000
25,778 25778000000
28,083 28083000000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
20,885 20885000000
22,667 22667000000
23,944 23944000000
19,029 19029000000
19,060 19060000000
22,096 22096000000
25,778 25778000000
28,083 28083000000
Total Liabilities & Equity
n/a
36,427 36427000000
39,629 39629000000
43,486 43486000000
48,871 48871000000
54,298 54298000000
66,125 66125000000
69,009 69009000000
71,449 71449000000
Remarks restated on n/a restated on Mar 1, 2010 n/a restated on Feb 25, 2011 n/a restated on Feb 29, 2012 n/a restated on Feb 27, 2013 n/a restated on Feb 24, 2014 n/a restated on Feb 19, 2015 n/a restated on Feb 16, 2016 n/a restated on Oct 28, 2016 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Net Income/Starting Line
3,078
4,052
4,605
4,627
3,683
4,345
5,081
5,158
6,939
Net Income
0
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Depreciation & Amortization
1,202
1,073
1,049
1,017
1,060
1,088
1,286
2,092
2,108
Non-Cash Items
1,562
436
573
460
82
494
317
184
-684
Stock-Based Compensation
0
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
0
Change in Working Capital
-441
427
109
-317
294
-45
-393
1,121
714
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
0
Cash from Operating Activities
5,401
5,988
6,336
5,787
5,119
5,882
6,291
8,555
9,077
Change in Fixed Assets & Intangibles
-1,267
-672
-530
-580
-567
-714
-673
-1,000
-375
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
-52
-2,565
-2,723
-3,475
437
-6,875
2,248
-4,982
-4,421
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
-697
-56
0
0
-701
-2,390
-9,434
-165
-359
Net Cash from Divestitures
0
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
0
Other Investing Activities
24
128
51
-97
45
-11
-610
395
-392
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
0
Cash from Investing Activities
-1,992
-3,165
-3,202
-4,152
-786
-9,990
-8,469
-5,752
-5,547
Dividends Paid
0
0
0
0
-500
-1,118
-1,415
-1,851
-2,396
Cash From (Repayment of) Debt
2,142
-1,009
980
2,471
7,887
4,810
4,683
-1,129
1,065
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
-4,823
-2,113
-3,208
-3,706
-8,073
-3,319
-536
48
-1,785
Increase in Capital Stock
0
0
0
0
0
0
0
0
0
Decrease in Capital Stock
0
0
0
0
0
0
0
0
0
Other Financing Activities
13
49
204
3
12
46
-6
55
-1
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
-2,668
-3,073
-2,024
-1,232
-674
419
2,726
-2,877
-3,117
Net Cash Before Disc. Operations and FX
741
-250
1,110
403
3,659
-3,689
548
-74
413
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
0
Net Cash Before FX
741
-250
1,110
403
3,659
-3,689
548
-74
413
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
0
Net Changes in Cash
741
-250
1,110
403
3,659
-3,689
548
-74
413
Remarks
restated on Mar 1, 2010 n/a
calculated values,
restated on Feb 25, 2011 n/a
calculated values,
restated on Feb 29, 2012 n/a
calculated values,
restated on Feb 27, 2013 n/a
calculated values,
restated on Feb 24, 2014 n/a
calculated values,
restated on Feb 19, 2015 n/a
calculated values,
restated on Feb 16, 2016 n/a
calculated values,
restated on Feb 16, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
About | Contact Forum | Legal
SimFin UG 2017 - Beta v. 1.42
Facebook | Twitter | Medium
Sumo